Science and Health
Low dose of aspirin may cut cancer, study finds
(China Daily)
Updated: 2010-10-23 08:40
 |
Large Medium Small |
LONDON - A low dose of aspirin may reduce colon cancer cases by a quarter and deaths by a third, a new study found.
But experts say aspirin's side effects of bleeding and stomach problems are too worrying for people who are not at high risk of the disease to start taking the drug for that reason alone.
European researchers looked at the 20-year results of four trials with more than 14,000 people that were originally done to study aspirin's use in preventing strokes. They found people taking baby or regular aspirin pills daily for about six years reduced their colon cancer risk by 24 percent and that deaths from the disease dropped by 35 percent. That was compared to those who took a dummy pill or nothing. There seemed to be no advantage to taking more aspirin than a baby-sized dose.
The study's conclusion that even low doses of aspirin can reduce colon cancer suggests the drug is inching its way toward being used for cancer prevention, though people should not start taking aspirin daily without consulting their doctor.
The studies used European baby aspirin of 75 milligrams and regular aspirin, 300 milligrams. US baby aspirin is 81 milligrams and regular aspirin, 325 milligrams.
If taken in high doses over a long period, aspirin can irritate the stomach, intestines and bowel, causing lesions and major bleeding.
Some researchers said the drug would benefit certain people.
"Anyone with any risk factors such as a family history (of colon cancer) or a previous polyp should definitely take aspirin," said Peter Rothwell, a professor at the University of Oxford. The finding also "tips the balance" for anyone considering aspirin to prevent heart attacks and strokes, he said.
No funding was provided for the study and it was published online on Friday in the journal Lancet.
Associated Press